FLU vaccine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

InfluenzaImmunogenicityMemory

93 competitors in Influenza

#DrugCompanyPhaseTrials

1

Influenza Vaccine

Novartis

Phase 3

712

Inactivated Influenza Vaccine

Sanofi

Phase 3

143

Live Attenuated Zoster Vaccine

CChangchun BCHT Biotechnology Co.

Phase 3

124

FLU vaccine

GSK

Phase 3

75

Relenza

GGlaxo Dba Glaxosmithkline

Phase 3

56

Seasonal Influenza Vaccine

Novartis

Phase 3

227

VAXIGRIP

GSK

Phase 3

98

Dexametasone

UUniversity of Malaya

Phase 3

19

Baloxavir

IInsight Therapeutics, LLC

Phase 3

310

GP681

JJiangxi Qingfeng Pharmaceutical Co. Ltd.

Phase 3

3Show 26 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Influenza7 trials

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

Completed·GSK·Phase 3·NCT05568797·1,045 enrolled

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Completed·GSK·Phase 1/2·NCT06382311·991 enrolled

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Completed·GSK·Phase 3·NCT05559476·1,029 enrolled

Show 4 more trials

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

Active, not recruiting·GSK·Phase 2·NCT07121192·776 enrolled

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Completed·GSK·Phase 1/2·NCT05975840·518 enrolled

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Completed·FFondazione Policlinico Universitario Agostino Gemelli IRCCS··NCT06304038·5,483 enrolled

Protection From Influenza: Determining the Impact of Prior Infection

Completed·HHealth Sciences North Research Institute··NCT03004040·45 enrolled

Congestive Heart Failure1 trial

Flu Vaccination in Congestive Heart Failure

Completed·LLa Fundacion Favaloro para la Investigacion y la Docencia Medica·Phase 4·NCT00664339·117 enrolled

Immunogenicity1 trial

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

Completed·NNanoPass Technologies Ltd·N/A·NCT00558649·180 enrolled

Immunosuppression1 trial

Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression

Completed·EEmory University·N/A·NCT01733056·43 enrolled

Memory1 trial

Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses

Active, not recruiting·—·Phase 4·NCT06824779·30 enrolled

3 more indications

Immune System1 trial

Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Completed·HHealth Sciences North Research Institute·Approved·NCT02297542·393 enrolled

Influenza, Human1 trial

A Phase 2a Randomized, Observer-Blind, Study to Evaluate the Immunogenicity and Safety of mRNA-Based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age and Older

Completed·GSK·Phase 2·NCT07204964·971 enrolled

Influenza Vaccine1 trial

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

Active, not recruiting·TThe Jackson Laboratory·Approved·NCT05518500·75 enrolled

Details

Drug Info

Related News